Vincerx Pharma Inc. (NASDAQ: VINC)
$0.68
-0.0108 ( -1.56% ) 162.1K
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.
Market Data
Open
$0.68
Previous close
$0.69
Volume
162.1K
Market cap
$20.72M
Day range
$0.67 - $0.75
52 week range
$0.57 - $9.37
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 29, 2024 |
8-k | 8K-related | 14 | Mar 29, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
8-k | 8K-related | 12 | Jan 16, 2024 |
10-q | Quarterly Reports | 58 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 14, 2023 |
8-k | 8K-related | 12 | Sep 15, 2023 |